Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06979323) titled 'Depemokimab Asthma Imaging and Bronchoscopy Sub-Study' on May 16.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: GlaxoSmithKline

Condition: Asthma

Intervention: Biological: Depemokimab

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: June 10, 2025

Target Sample Size: 150

To know more, visit https://clinicaltrials.gov/ct2/show/NCT06979323

Published by HT Digital Content Services with permission from Health Daily Digest....